Reduction of immune activation with chloroquine therapy during chronic HIV infection

Journal of Virology

Volumn 84, Issue 22, 2010, Pages 12082-12086

  Murray, Shannon M ^a   Down, Carrie M ^a,c   Boulware, David R ^b   Stauffer, William M ^b   Cavert, Winston P ^b   Schacker, Timothy W ^b   Brenchley, Jason M ^a   Douek, Daniel C ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; KI 67 ANTIGEN; PLACEBO;

ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHLOROQUINE; CHRONIC DISEASE; DOWN-REGULATION; HIV INFECTIONS; HUMANS; KI-67 ANTIGEN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 78049505077     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01466-10     Document Type: Article

References (22)

1. Benito, J. M., J. M. Zabay, J. Gil, M. Bermejo, A. Escudero, E. Sanchez, and E. Fernandez-Cruz. 1997. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 14:128-135.
2. Bofill, M., and N. J. Borthwick. 2000. CD38 in health and disease. Chem. Immunol. 75:218-234.
3. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, B. R. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, J. N. Martin, F. M. Hecht, L. J. Picker, M. M. Lederman, S. G. Deeks, and D. C. Douek. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371.
4. Brenchley, J. M., L. E. Ruff, J. P. Casazza, R. A. Koup, D. A. Price, and D. C. Douek. 2006. Preferential infection shortens the life span of human immunodeficiency virus-specific CD4+ T cells in vivo. J. Virol. 80:6801-6809.
5. Catalfamo, M., M. Di Mascio, Z. Hu, S. Srinivasula, V. Thaker, J. Adelsberger, A. Rupert, M. Baseler, Y. Tagaya, G. Roby, C. Rehm, D. Follmann, and H. C. Lane. 2008. HIV infection-associated immune activation occurs by two distinct pathways that differentially affect CD4 and CD8 T cells. Proc. Natl. Acad. Sci. U. S. A. 105:19851-19856.
6. Chiang, G., M. Sassaroli, M. Louie, H. Chen, V. J. Stecher, and K. Sperber. 1996. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine. Clin. Ther. 18:1080-1092.
7. Funderburg, N., A. A. Luciano, W. Jiang, B. Rodriguez, S. F. Sieg, and M. M. Lederman. 2008. Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 3:e1915.
8. Giorgi, J. V., H. N. Ho, K. Hirji, C. C. Chou, L. E. Hultin, S. O'Rourke, L. Park, J. B. Margolick, J. Ferbas, and J. P. Phair. 1994. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels. The Multicenter AIDS Cohort Study Group. J. Infect. Dis. 170:775-781.
9. Giorgi, J. V., L. E. Hultin, J. A. McKeating, T. D. Johnson, B. Owens, L. P. Jacobson, R. Shih, J. Lewis, D. J. Wiley, J. P. Phair, S. M. Wolinsky, and R. Detels. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179:859-870.
10. Hunt, P. W., J. N. Martin, E. Sinclair, B. Bredt, E. Hagos, H. Lampiris, and S. G. Deeks. 2003. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. J. Infect. Dis. 187:1534-1543.
11. Kalia, S., and J. P. Dutz. 2007. New concepts in antimalarial use and mode of action in dermatology. Dermatol. Ther. 20:160-174.
12. Kovacs, J. A., R. A. Lempicki, I. A. Sidorov, J. W. Adelsberger, B. Herpin, J. A. Metcalf, I. Sereti, M. A. Polis, R. T. Davey, J. Tavel, J. Falloon, R. Stevens, L. Lambert, R. Dewar, D. J. Schwartzentruber, M. R. Anver, M. W. Baseler, H. Masur, D. S. Dimitrov, and H. C. Lane. 2001. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194:1731-1741.
13. Kuller, L. H., R. Tracy, W. Belloso, S. De Wit, F. Drummond, H. C. Lane, B. Ledergerber, J. Lundgren, J. Neuhaus, D. Nixon, N. I. Paton, and J. D. Neaton. 2008. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 5:e203.
14. Martinson, J. A., C. J. Montoya, X. Usuga, R. Ronquillo, A. L. Landay, and S. N. Desai. 2010. Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation. Antimicrob. Agents Chemother. 54:871-881.
15. Paton, N. I., J. Aboulhab, and F. Karim. 2002. Hydroxychloroquine, hydroxy-carbamide, and didanosine as economic treatment for HIV-1. Lancet 359: 1667-1668.
16. Pitcher, C. J., S. I. Hagen, J. M. Walker, R. Lum, B. L. Mitchell, V. C. Maino, M. K. Axthelm, and L. J. Picker. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:29-43.
17. Rodriguez, B., A. K. Sethi, V. K. Cheruvu, W. Mackay, R. J. Bosch, M. Kitahata, S. L. Boswell, W. C. Mathews, D. R. Bangsberg, J. Martin, C. C. Whalen, S. Sieg, S. Yadavalli, S. G. Deeks, and M. M. Lederman. 2006. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296:1498-1506.
18. Sachsenberg, N., A. S. Perelson, S. Yerly, G. A. Schockmel, D. Leduc, B. Hirschel, and L. Perrin. 1998. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187:1295-1303.
19. Savarino, A., J. R. Boelaert, A. Cassone, G. Majori, and R. Cauda. 2003. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect. Dis. 3:722-727.
20. Savarino, A., L. Di Trani, I. Donatelli, R. Cauda, and A. Cassone. 2006. New insights into the antiviral effects of chloroquine. Lancet Infect. Dis. 6:67-69.
21. Sperber, K., G. Chiang, H. Chen, W. Ross, E. Chusid, M. Gonchar, R. Chow, and O. Liriano. 1997. Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1. Clin. Ther. 19:913-923.
22. Sperber, K., M. Louie, T. Kraus, J. Proner, E. Sapira, S. Lin, V. Stecher, and L. Mayer. 1995. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin. Ther. 17:622-636.